fda compounding semaglutide enforcement news november 2025 π¨ Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these FDA Moves to Permanently Close
Description
J., Taylor, L

The drug works as a potent partial agonist of the GLP-1 receptor

Strategies include eating bland foods (rice, crackers, bananas, toast) on the day after injection, sipping ginger tea or ginger ale, avoiding spicy and high-fat foods for 48 hours post-injection, and staying well-hydrated with small sips throughout the day rather than large gulps

These are genuine pharmaceutical products manufactured by Novo Nordisk

At $99 after the first month of treatment, this test helps providers predict individual response and personalize medication selection and dosing from the outset
